Live Breaking News & Updates on Q Rich Creations

Stay updated with breaking news from Q rich creations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Serum Institute to invest 240 million pounds in UK, expand vaccine business


Serum Institute to invest 240 million pounds in UK, expand vaccine business
Serum Institute to invest 240 million pounds in UK, expand vaccine business
The Serum Institute of India will invest GBP 240 million in the UK to expand its vaccine business and set up a new sales office creating a large number of jobs, Downing Street has announced as part of plans for a GBP 1 billion India-UK Enhanced Trade Partnership.
advertisement
UPDATED: May 4, 2021 09:19 IST
The Serum Institute of India will invest GBP 240 million in the UK to expand its vaccine business. (Reuters)
The Serum Institute of India will invest GBP 240 million in the UK to expand its vaccine business and set up a new sales office creating a large number of jobs, Downing Street has announced as part of plans for a GBP 1 billion India-UK Enhanced Trade Partnership creating around 6,500 jobs in Britain. The Pune-based vaccine manufacturer is among a list of nearly 20 Indian companies across sectors su ....

United Kingdom , North Lanarkshire , Deepak Bagla , Narendra Modi , Aayushmaan Bharat , Sumit Jamuar , Boris Johnson , Global Gene Corp , National Healthcare Mission , Morningside Pharmaceuticals , Que Processing Services , Bio Products Laboratory , United Kingdom Enhanced Trade Partnership , Department For International , Ctrls Data Centers , Serum Institute Of India , Serum Institute , Downing Street , India United Kingdom Enhanced Trade Partnership , Wellcome Genome Campus , Human Genome , United Kingdom Prime Minister Boris Johnson , Genome United Kingdom , Prime Minister Narendra Modi , Rgene Corp , Q Rich Creations ,

Serum Institute to invest 240 million pounds in UK; leads cross-sector Indian investments


Serum Institute to invest 240 million pounds in UK; leads cross-sector Indian investments
SECTIONS
Last Updated: May 04, 2021, 09:28 AM IST
Share
Synopsis
The Pune-based vaccine manufacturer is among a list of nearly 20 Indian companies across sectors such as healthcare, biotech and software services to announce significant investment plans in the UK.
Agencies
It was also revealed that the Serum Institute of India (SII) has started phase one trials in the UK of a nasal vaccine against coronavirus.
The Serum Institute of India will invest GBP 240 million in the UK to expand its vaccine business and set up a new sales office creating a large number of jobs, Downing Street has announced as part of plans for a GBP 1 billion India-UK Enhanced Trade Partnership creating around 6,500 jobs in Britain. The Pune-based vaccine manufacturer is among a list of nearly 20 Indian companies across sectors such as healthcare, biotech and software services to announce ....

United Kingdom , North Lanarkshire , Deepak Bagla , Narendra Modi , Aayushmaan Bharat , Sumit Jamuar , Boris Johnson , Global Gene Corp , National Healthcare Mission , Morningside Pharmaceuticals , Que Processing Services , Bio Products Laboratory , United Kingdom Enhanced Trade Partnership , Department For International , Ctrls Data Centers , Serum Institute Of India , Serum Institute , Downing Street , India United Kingdom Enhanced Trade Partnership , Wellcome Genome Campus , Human Genome , United Kingdom Prime Minister Boris Johnson , Genome United Kingdom , Prime Minister Narendra Modi , Rgene Corp , Q Rich Creations ,

Adar Poonawalla's Serum Institute to invest 240 mn pounds to expand vaccine business in UK


Adar Poonawalla s Serum Institute to invest 240 mn pounds to expand vaccine business in UK
Serum Institute of India (SII), which is known globally for its vaccine production capacity is among 20 Indian companies across sectors (healthcare, biotech and software services) to announce massive investment plans in the UK
BusinessToday.In | May 4, 2021 | Updated 13:05 IST
Adar Poonawalla
Adar Poonawalla-helmed Serum Institute will pump in 240 million British pounds to expand its vaccine business and setting up a new sales office in the UK.  This investment is part of plans for 1 billion British pound India-UK Enhanced Trade Partnership, which will create approximately 6,500 jobs in the UK, Downing Street announced. ....

United Kingdom , Narendra Modi , Adar Poonawalla , Mehak Agarwal , Boris Johnson , United Kingdom Enhanced Trade Partnership , Global Gene Corp , Serum Institute , Serum Institute Of India , India United Kingdom Enhanced Trade Partnership , Downing Street , Prime Minister Modi , United Kingdom Prime Minister Boris Johnson , Global Gene , Wellcome Genome Campus Site , Human Genome , Q Rich Creations , Sterlite Technologies , Serum Institute Vaccine Production , Serum Institute Vaccine Production Capacity , Serum Institute Vaccine Production Uk , Serum Institute Vaccine Production Capacity Uk , India Uk Enhanced Trade Partnership , Modi Johnson Virtual Talks , ஒன்றுபட்டது கிஂக்டம் , நரேந்திர மோடி ,